{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:37:11Z","timestamp":1787960231996,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd003598.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000}}],"reference-count":393,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003598.pub3","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T09:06:14Z","timestamp":1722416774000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antihypertensive treatment for kidney transplant recipients"],"prefix":"10.1002","volume":"2024","author":[{"given":"Patrizia","family":"Natale","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"},{"name":"Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences; University of Foggia; Foggia Italy"},{"name":"Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J); University of Bari Aldo Moro; Bari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela KL","family":"Mooi","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Christchurch Hospital, Te Whatu Ora Waitaha Canterbury; Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suetonia C","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Otago Christchurch; Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas B","family":"Cross","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Christchurch Hospital, Te Whatu Ora Waitaha Canterbury; Christchurch New Zealand"},{"name":"New Zealand Clinical Research, 3\/264 Antigua St; Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess E","family":"Cooper","sequence":"additional","affiliation":[{"name":"NHMRC Clinical Trials Centre, Faculty of Medicine and Health; The University of Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela C","family":"Webster","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"},{"name":"NHMRC Clinical Trials Centre, Faculty of Medicine and Health; The University of Sydney; Sydney Australia"},{"name":"Westmead Applied Research Centre; The University of Sydney at Westmead; Westmead Australia"},{"name":"Department of Transplant and Renal Medicine; Westmead Hospital; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Masson","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine; Royal Free London NHS Foundation Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"},{"name":"College of Medicine and Public Health; Flinders University; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J); University of Bari Aldo Moro; Bari Italy"},{"name":"Cochrane Kidney and Transplant, Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,7,31]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD003598.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/01.TP.0000440952.29757.66","article-title":"Uric acid and allograft loss from interstitial fibrosis\/tubular atrophy: post hoc analysis from the Angiotensin II Blockade in Chronic Allograft Nephropathy Trial","volume":"97","author":"Hart","year":"2014","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003598.pub3-BIB0002|cit2","first-page":"270","article-title":"Elevated uric acid is not associated with a faster GFR decline in renal transplant recipients [abstract no: 804]","volume":"11","author":"Ibrahim","year":"2011","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1681\/ASN.2012080777","article-title":"Angiotensin II blockade in kidney transplant recipients","volume":"24","author":"Ibrahim","year":"2013","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD003598.pub3-BIB0004|cit4","first-page":"11B","article-title":"A randomized 5-year trial of angiotensin II blockade vs. placebo in kidney transplant recipients [abstract no: SA-PO1122]","volume":"23","author":"Ibrahim","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.2013.278","article-title":"The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure [Erratum in: Kidney Int. 2015 Jan;87(1):243 Note: Najafian, Behzad [Added]; PMID: 25549130]","volume":"85","author":"Issa","year":"2014","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/ndt\/gfp668","article-title":"GFR-estimating models in kidney transplant recipients on a steroid-free regimen","volume":"25","author":"Kukla","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000357594","article-title":"Cystatin C enhances glomerular filtration rate estimating equations in kidney transplant recipients","volume":"39","author":"Kukla","year":"2014","journal-title":"American Journal of Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0008|cit8","first-page":"781","article-title":"Angiotensin II blockade and fibroblast growth factor-23 in stable kidney transplant recipients [abstract no: D258]","volume":"16","author":"Sanchez","year":"2016","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0009|cit9","first-page":"226","article-title":"Pulse pressure and GFR decay in kidney transplant recipients [abstract no: 60]","volume":"16","author":"Sanchez","year":"2016","journal-title":"American Journal of Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/ctr.12514","article-title":"Daily fluid intake and outcomes in kidney recipients: post hoc analysis from the randomized ABCAN trial","volume":"29","author":"Weber","year":"2015","journal-title":"Clinical Transplantation"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD003598.pub3-BIB0011|cit11","first-page":"1061A","article-title":"Daily fluid intake and outcomes in kidney recipients: post-hoc analysis from the randomized ABCAN trial [abstract no: PUB725]","volume":"25","author":"Weber","year":"2014","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0012|cit12","first-page":"2383","article-title":"Effect of diltiazem in the prevention of acute tubular necrosis, acute rejection, and cyclosporine levels","volume":"23","author":"Alcaraz","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0013|cit13","first-page":"50","article-title":"Influence of the calcium blocker diltiazem on the prevention of acute renal failure after renal transplantation","volume":"24","author":"Oppenheimer","year":"1992","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0014|cit14","first-page":"A70","article-title":"The antihypertensive and renal protective effects of amlodipine versus cilazapril in renal transplant recipients with hypertension [abstract]","volume":"15","author":"Almeshari","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7-8","key":"10.1002\/14651858.CD003598.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1016\/S0041-1345(01)02450-2","article-title":"Is losartan as effective as enalapril on posttransplant persistent proteinuria?","volume":"33","author":"Altiparmak","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/TP.0b013e3181bf13d9","article-title":"Randomized controlled trial: lisinopril reduces proteinuria, ammonia, and renal polypeptide tubular catabolism in patients with chronic allograft nephropathy","volume":"89","author":"Amara","year":"2010","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0017|cit17","unstructured":"Sharma A Amara A Alexander J Shalamanova L Alfirevic A Pirmohammed M Lisinopril and chronic allograft nephropathy (CAN): graft function, proteinuria and proximal renal tubular (PTC) peptide (Trasylol) catabolism: a novel RCT [abstract no: O043] British Transplantation Society (BTS).11th Annual Congress; 2008 Apr 16-18; Glasgow, UK 2008"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.transproceed.2006.08.066","article-title":"Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study","volume":"38","author":"Andres","year":"2006","journal-title":"Transplantation Proceedings"},{"issue":"Sept","key":"10.1002\/14651858.CD003598.pub3-BIB0019|cit19","first-page":"692A","article-title":"Valsartan is effective in patients with post-transplant hypertension [abstract no: A3639]","volume":"11","author":"Jardine","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1016\/j.transproceed.2005.09.098","article-title":"No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem","volume":"37","author":"Aros","year":"2005","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0021|cit21","first-page":"S193","article-title":"A randomised trial of effects of AT1-rezeptor- vs. calcium-channel-blockade on arterial function in hypertensive renal transplant recipients [abstract]","volume":"126","author":"Barenbrock","year":"2001","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0022|cit22","first-page":"S196","article-title":"Studies of effects of antihypertensive treatment by AT1-receptor- vs. calcium-channel-blockade on sympathetic nerve activity in renal transplant recipients [abstract]","volume":"126","author":"Kosch","year":"2001","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0023|cit23","first-page":"1072","article-title":"Isradipine (ISR) in the treatment of hypertension in renal transplant patients (RTP) on cyclosporin (CSA): a randomized open-label cross-over study [abstract]","volume":"6","author":"Barri","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0024|cit24","first-page":"1035","article-title":"Use of ACE inhibitors to control transplant erythrocytosis [abstract]","volume":"8","author":"Beckingham","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD003598.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/ndt\/10.12.2316","article-title":"A randomized placebo-controlled study of enalapril in the treatment of erythrocytosis after renal transplantation","volume":"10","author":"Beckingham","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0026|cit26","first-page":"730","article-title":"A randomized placebo-controlled study of enalapril in post-transplant erythrocytosis [abstract]","volume":"10","author":"Woodrow","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/11593800-000000000-00000","article-title":"Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy","volume":"11","author":"Cai","year":"2011","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.ijcard.2011.08.673","article-title":"Comparing antihypertensive effect and plasma CsA concentration between amlodipine and valsartan regimen in hypertensive renal transplant patients with CsA therapy [abstract no: 0039]","volume":"152","author":"Huang","year":"2011","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5414\/CNP58103","article-title":"Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine","volume":"58","author":"Calo","year":"2002","journal-title":"Clinical Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000186262","article-title":"Interaction between ciclosporin and diltiazem in renal transplant patients","volume":"57","author":"Campistol","year":"1991","journal-title":"Nephron"},{"issue":"25-28","key":"10.1002\/14651858.CD003598.pub3-BIB0031|cit31","first-page":"855","article-title":"Effect of sustained release alprenolol in hypertension uncontrolled by chlorothiazide and dihydralazine. Study in double blind (author's transl)","volume":"54","author":"Cartier","year":"1978","journal-title":"Semaine des Hopitaux"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003598.pub3-BIB0032|cit32","first-page":"47","article-title":"Comparative randomized study of calcium channel blockers vs. angiotensin converting enzyme inhibitors in the treatment of hypertension under cyclosporine immunosuppression","volume":"13","author":"Castelao","year":"1993","journal-title":"Nefrologia"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0033|cit33","unstructured":"Castelao AM Grino JM Galceran JM Andres E GilVernet S Seron D Calcium antagonists (verapamil) vs ACEI (enalapril) in the treatment of hypertension of kidney transplanted patients under cyclosporin A and prednisone immunosuppression. A randomized study [abstract] 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel 1993 250"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.transproceed.2022.02.012","article-title":"Short-term effects of losartan on cardiovascular risk and allograft injury biomarkers in kidney transplant recipients","volume":"54","author":"Kuzmiuk-Glembin","year":"2022","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000045819","article-title":"Comparison of enalapril and losartan in the treatment of posttransplant erythrocytosis","volume":"86","author":"Celik","year":"2000","journal-title":"Nephron"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0036|cit36","first-page":"A292","article-title":"Enalapril and losartan on the treatment of posttransplantation erythrocytosis [abstract]","volume":"14","author":"Celik","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/ndt\/gfg341","article-title":"Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients","volume":"18","author":"Chanard","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0038|cit38","first-page":"882A","article-title":"Amlodipine reduces cyclosporine-induced hyperuricemia in hypertensive renal transplant recipients [abstract no: A4613]","volume":"12","author":"Chanard","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"E272","DOI":"10.1111\/ctr.12101","article-title":"Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism - a prospective, randomized, controlled study","volume":"27","author":"Chen","year":"2013","journal-title":"Clinical Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"E272","DOI":"10.1111\/ctr.12101","article-title":"Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism - a prospective, randomized, controlled study","volume":"27","author":"Chen","year":"2013","journal-title":"Clinical Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00007890-199302000-00014","article-title":"Diltiazem in renal allograft recipients receiving cyclosporine","volume":"55","author":"Chrysostomou","year":"1993","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0042|cit42","first-page":"2127","article-title":"A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results","volume":"22","author":"Kelly","year":"1990","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00007890-201407151-02329","article-title":"Standard vs. low dose extended-release tacrolimus (Advagraf) in de novo renal transplant: 6-month interim analysis [abstract no: D3067]","volume":"98","author":"Cockfield","year":"2014","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0044|cit44","first-page":"231","article-title":"Impact of antihypertensive (AHT) choice and Advagraf dose on interstitial fibrosis\/tubular atrophy (IF\/TA) and IF\/TA progression in renal allografts 24 months post-transplantation (Tx) [abstract no: 70]","volume":"17","author":"Cockfield","year":"2017","journal-title":"American Journal of Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/ajt.15225","article-title":"Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi\/ARB on the histology and function of renal allografts","volume":"19","author":"Cockfield","year":"2019","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0046|cit46","first-page":"231","article-title":"Impact of antihypertensive (AHT) choice and advagraf dose on immunologic events in renal allografts 24 months post-transplantation (Tx) [abstract]","volume":"17","author":"Rush","year":"2017","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0047|cit47","first-page":"966","article-title":"Long-term impact of antihypertensive treatment and tacrolimus dose in renal allograft recipients 5 years post-transplantation [abstract no: C207]","volume":"19","author":"Rush","year":"2019","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1111\/tri.1992.5.s1.60","article-title":"Verapamil (VP) improves the outcome after renal transplantation (CRT)","volume":"5 Suppl 1","author":"Dawidson","year":"1992","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0049|cit49","first-page":"1379","article-title":"Verapamil prevents posttransplant delayed function and cyclosporine A nephrotoxicity","volume":"22","author":"Dawidson","year":"1990","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1681\/ASN.V25983","article-title":"Verapamil improves the outcome after cadaver renal transplantation","volume":"2","author":"Dawidson","year":"1991","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003598.pub3-BIB0051|cit51","first-page":"500","article-title":"Losartan could prevent progression of chronic allograft nephropathy: a prospective randomized study [abstract no: T683]","volume":"18","author":"El Agroudy","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000072820","article-title":"Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients","volume":"23","author":"El Agroudy","year":"2003","journal-title":"American Journal of Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0053|cit53","first-page":"84","article-title":"ARBS usage after kidney transplantation and safety; a randomized, double-blinded placebo-controlled study [abstract]","volume":"13","author":"Elham","year":"2019","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD003598.pub3-BIB0054|cit54","first-page":"200","article-title":"A randomized controlled trial comparing losartan to amlodipine as initial therapy for hypertension in the immediate post transplant period [abstract no: 174]","volume":"5","author":"Formica","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/ndt\/gfk058","article-title":"A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period","volume":"21","author":"Formica","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00005344-199006166-00004","article-title":"Calcium channel blockers for kidney protection","volume":"16 Suppl 6","author":"Frei","year":"1990","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0057|cit57","first-page":"3539","article-title":"Preoperative graft reperfusion with a calcium antagonist improves initial function: preliminary results of a prospective randomized trial in 110 kidney recipients","volume":"19","author":"Frei","year":"1987","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1399-0012.2010.01372.x","article-title":"Angiotensin converting enzyme inhibitor use soon after renal transplantation: a randomized, double-blinded placebo-controlled safety study","volume":"25","author":"Glicklich","year":"2011","journal-title":"Clinical Transplantation"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD003598.pub3-BIB0059|cit59","first-page":"351A","article-title":"The use of ACE inhibitors in the early post-renal transplant period [abstract no: TH-PO1049]","volume":"20","author":"Gordillo","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0041-1345(02)03059-2","article-title":"A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients","volume":"34","author":"Gossmann","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0061|cit61","first-page":"1114","article-title":"A randomized, double blind, placebo controlled study of gallo-pamil in cyclosporine treated renal transplant recipients [abstract no: 1136]","volume":"6","author":"Scheuermann","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/00365599.1984.11783718","article-title":"Angiotensin I-converting enzyme inhibition after renal transplantation","volume":"79","author":"Gronhagen-Riska","year":"1984","journal-title":"Scandinavian Journal of Urology & Nephrology Supplementum"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0063|cit63","first-page":"1223","article-title":"Effects of diltiazem on arterial pressure and renal function in renal transplanted and cyclosporin A treated subjects. Results after 3 months of a prospective study","volume":"82","author":"Guerin","year":"1989","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1399-0012.2007.00643.x","article-title":"Enalapril\/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial","volume":"21","author":"Halimi","year":"2007","journal-title":"Clinical Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0065|cit65","first-page":"445","article-title":"Effect of nifedipine on immediate graft function on cyclosporin-treated renal transplant patients: a prospective randomized study [abstract]","volume":"79","author":"Donnelly","year":"1992","journal-title":"British Journal of Surgery"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD003598.pub3-BIB0066|cit66","first-page":"600","article-title":"Renal transplantation: nifedipine for the nonstarters? A prospective randomised study","volume":"25","author":"Donnelly","year":"1993","journal-title":"Transplantation Proceedings"},{"issue":"12","key":"10.1002\/14651858.CD003598.pub3-BIB0067|cit67","first-page":"2387","article-title":"Beneficial effects of oral nifedipine on cyclos(CsA)-treated renal transplant recipients [abstract]","volume":"10","author":"Harper","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0068|cit68","doi-asserted-by":"crossref","unstructured":"Harper SJ Harris K Jurewicz A Walls J Veitch P Feehally J Beneficial effects of oral nifedipine on cyclosporin (cya) treated renal allograft recipients - a randomised prospective study [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain) 1995 381","DOI":"10.1007\/BF00336388"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1432-2277.1996.tb00865.x","article-title":"The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients--a randomised prospective study","volume":"9","author":"Harper","year":"1996","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/00007890-199210000-00037","article-title":"Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients--a randomized prospective study","volume":"54","author":"Harper","year":"1992","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1111\/tri.1992.5.s1.69","article-title":"Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients","volume":"5 Suppl 1","author":"Harper","year":"1992","journal-title":"Transplant International"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub3-BIB0072|cit72","first-page":"904","article-title":"Protective effects of nifedipine in immediate and 6-month graft function in cyclosporin A treated renal allograft recipients [abstract]","volume":"6","author":"Harper","year":"1991","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jcp.47.9.839","article-title":"Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A","volume":"47","author":"McCulloch","year":"1994","journal-title":"Journal of Clinical Pathology"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.1111\/j.1432-2277.1994.tb01380.x","article-title":"Cyclosporin, nifedipine and gingival hyperplasia: a randomized controlled study","volume":"7 Suppl 1","author":"Morgan","year":"1994","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0075|cit75","unstructured":"Hausberg M Barenbrock M Hohage H Heidenreich S Rahn KH Efficacy and safety of the ace-inhibitor quinapril as compared to the beta-blocker atenolol in hypertensive renal allograft recipients [abstract] 35th Congress European Renal Association. European Dialysis and Transplantation Association; 1998 Jun 6-9; Rimini, Italy 1998 359"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/01.HYP.33.3.862","article-title":"ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients","volume":"33","author":"Hausberg","year":"1999","journal-title":"Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0002-9149(00)01024-9","article-title":"Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation","volume":"86","author":"Suwelack","year":"2000","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0041-1345(02)03058-0","article-title":"Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition","volume":"34","author":"Suwelack","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2003.tb00306.x","article-title":"Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients","volume":"16","author":"Suwelack","year":"2003","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"Suwelack B Witta J Hausberg M Barenbrock M Rahn KH Arterial vessel wall hypertrophy in renal transplant recipients: effects of ACE inhibitor and B - blocker treatment [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998 Jun 6-9; Rimini, Italy 1998 195","DOI":"10.1097\/00007890-199805131-00585"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0081|cit81","first-page":"2239","article-title":"Usefulness and safety of treatment with captopril in posttransplant erythrocytosis","volume":"27","author":"Hernandez","year":"1995","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0082|cit82","first-page":"940","article-title":"Usefulness of treatment with captopril on post-transplant erythrocytosis (PTE). A controlled study [abstract no: 56P]","volume":"4","author":"Hernandez","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0083|cit83","first-page":"1041","article-title":"Effect of captopril on post-transplant erythrocytosis: a controlled study [abstract]","volume":"8","author":"Hernandez","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0084|cit84","first-page":"708A","article-title":"Regression of left ventricular hypertrophy (LVH) by lisinopril after renal transplantation (RT). Role of angiotensin-converting-enzyme (ACE) gene polymorphism [abstract no: T795]","volume":"9","author":"Hernandez","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0085|cit85","first-page":"714A","article-title":"Regression of left ventricular hypertrophy (LVH) by an angiotensin-converting-enzyme inhibitor (ACEI) after renal transplantation (RT) [abstract no: A3317]","volume":"8","author":"Hernandez","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1523-1755.2000.00239.x","article-title":"Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism","volume":"58","author":"Hernandez","year":"2000","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0087|cit87","doi-asserted-by":"crossref","unstructured":"Inigo P Campistol JM Lario S Bescos M Oppenheimer F Losartan normalizes the plasma levels of TGF-\u00df1 in a random, crossover study (losartan vs. amlodipine) in renal transplant patients treated with CsA [abstract no: 0657] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000","DOI":"10.1097\/00007890-200004271-01112"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1681\/ASN.V124822","article-title":"Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients","volume":"12","author":"Inigo","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0089|cit89","doi-asserted-by":"crossref","unstructured":"Inigo P Campistol JM Piera C Oppenheimer F Effects on renal hemodynamics of losartan vs. amlodipine in a cross-over trial in renal transplant patients [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000","DOI":"10.1097\/00007890-200004271-00671"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0090|cit90","first-page":"759A","article-title":"Losartan normalizes the plasma levels of TGF-b1 in a random, crossover study (losartan vs amlodipine) in renal transplant patients treated with cyclosporine [abstract no: A3838]","volume":"10","author":"Inigo","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0091|cit91","doi-asserted-by":"crossref","unstructured":"Kamper A Nielsen AH Uricosuric effect of losartan in renal transplanted patients [abstract no: P0607] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000","DOI":"10.1016\/S0041-1345(00)02385-X"},{"issue":"1-2","key":"10.1002\/14651858.CD003598.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0041-1345(00)02385-X","article-title":"Uricosuric effect of losartan in renal transplanted patients","volume":"33","author":"Kamper","year":"2001","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00007890-200108270-00019","article-title":"Uricosuric effect of losartan in patients with renal transplants","volume":"72","author":"Kamper","year":"2001","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0094|cit94","first-page":"324","article-title":"The effect of enalapril on the progression of chronic allograft nephropathy [abstract no: T490]","volume":"17","author":"Kim","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1097\/TXD.0000000000000880","article-title":"Impact of using alternative graft function endpoints: a secondary analysis of a kidney transplant trial","volume":"5","author":"Fergusson","year":"2019","journal-title":"Transplantation Direct"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jclinepi.2018.02.001","article-title":"The win ratio approach did not alter study conclusions and may mitigate concerns regarding unequal composite end points in kidney transplant trials","volume":"98","author":"Fergusson","year":"2018","journal-title":"Journal of Clinical Epidemiology"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD003598.pub3-BIB0097|cit97","first-page":"392A","article-title":"Urinary excretion of ACE, ACE2 and podocyte proteins in proteinuric renal transplant patients [abstract no: F-PO1224]","volume":"20","author":"Jadhav","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ndt\/gfm574","article-title":"The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation--study design","volume":"23","author":"Knoll","year":"2008","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S2213-8587(15)00368-X","article-title":"Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial","volume":"4","author":"Knoll","year":"2016","journal-title":"The Lancet Diabetes & Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2125.2003.01908.x","article-title":"Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin","volume":"56","author":"Kumana","year":"2003","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"Oct","key":"10.1002\/14651858.CD003598.pub3-BIB0101|cit101","first-page":"526A","article-title":"Calcium channel blockade and preservation of renal allograft function in cyclosporine-treated recipients: a multicentre, prospective randomized, placebo-controlled, 2-year study [abstract no: SA-PO1044]","volume":"15","author":"Kuypers","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.TP.0000137793.23371.42","article-title":"Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study","volume":"78","author":"Kuypers","year":"2004","journal-title":"Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD003598.pub3-BIB0103|cit103","first-page":"432","article-title":"Calcium channel blockade and prevention of renal graft function deterioration in cyclosporine-treated recipients: a multi-centre prospective, randomized, placebo-controlled, 2-year study [abstract no: 1001]","volume":"4","author":"Kuypers","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0104|cit104","first-page":"1033","article-title":"Acute renal allograft rejection, morphology and immunology in 'zero-hour' biopsies and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules [abstract]","volume":"8","author":"Andersen","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0105|cit105","first-page":"446","article-title":"Morphology and immunology in 'zero-hour' and follow-up biopsies from 39 renal allotransplanted patients with special emphasis on acute rejection [abstract]","volume":"9","author":"Andersen","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ndt\/9.5.543","article-title":"Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study","volume":"9","author":"Ladefoged","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0107|cit107","first-page":"A276","article-title":"A randomised placebo controlled study on initial isradipine therapy in renal transplantation: long-term results [abstract]","volume":"15","author":"Lehtonen","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/tpj.2010.42","article-title":"Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective","volume":"11","author":"Li","year":"2011","journal-title":"Pharmacogenomics Journal"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD003598.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"S376","DOI":"10.1016\/j.ekir.2019.05.976","article-title":"A pilot study of spironolactone on the endothelial glycocalyx in kidney transplant recipients [abstract no: MON-181]","volume":"4","author":"Liew","year":"2019","journal-title":"Kidney International Reports"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0110|cit110","first-page":"1102","article-title":"Ciclosporine nephrotoxicity can be counteracted by a calcium antagonist (felodipine) in acute and short-term studies [abstract no: 1126]","volume":"6","author":"Madsen","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/ndt\/13.9.2327","article-title":"The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation","volume":"13","author":"Madsen","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0112|cit112","first-page":"S94","article-title":"Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies","volume":"55","author":"Pedersen","year":"1996","journal-title":"Kidney International - Supplement"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00007890-201407151-00373","article-title":"Effect of ramipril on urinary protein excretion in maintenance renal transplant patients converted to sirolimus [abstract no: 2213]","volume":"98","author":"Mandelbrot","year":"2014","journal-title":"Transplantation"},{"issue":"12","key":"10.1002\/14651858.CD003598.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"3174\u201384","DOI":"10.1111\/ajt.13384","article-title":"Effect of ramipril on urinary protein excretion in maintenance renal transplant patients converted to sirolimus","volume":"15","author":"Mandelbrot","year":"2015","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0115|cit115","first-page":"401","article-title":"Enalapril effectively treats diabetic and non-diabetic renal allograft recipients with post-transplant hypertension [abstract]","volume":"37","author":"Markell","year":"1990","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1046\/j.1523-1755.1998.06826.x","article-title":"Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin","volume":"68","author":"Martinez-Castelao","year":"1998","journal-title":"Kidney International - Supplement"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0117|cit117","first-page":"881A","article-title":"Double blind, crossover, comparative study of doxazosin vs enalapril in the treatment of hypertension in renal transplantation under cyclosporin immunosuppression [abstract no: A4609]","volume":"12","author":"Castelao","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0041-1345(01)02818-4","article-title":"Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression","volume":"34","author":"Martinez-Castelao","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0119|cit119","first-page":"1808","article-title":"Aldosterone blockade in children with chronic allograft nephropathy [abstract no: O-10]","volume":"25","author":"Medeiros","year":"2010","journal-title":"Pediatric Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003598.pub3-BIB0120|cit120","first-page":"411","article-title":"Aldosterone blockade in children with chronic allograft nephropathy [abstract no: 1296]","volume":"10","author":"Medeiros","year":"2010","journal-title":"American Journal of Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2215\/CJN.05300516","article-title":"Randomized controlled trial of mineralocorticoid receptor blockade in children with chronic kidney allograft nephropathy","volume":"12","author":"Medeiros","year":"2017","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0122|cit122","first-page":"71","article-title":"Mineralocorticoid receptor blockade in children with chronic allograft injury [abstract no: 116]","volume":"17","author":"Medeiros","year":"2013","journal-title":"Pediatric Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0123|cit123","first-page":"98","article-title":"Aldosterone blockade in children with chronic allograft nephropathy [abstract no: 234]","volume":"15","author":"Medeiros","year":"2011","journal-title":"Pediatric Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1399-0012.2005.00416.x","article-title":"Predictors of health-related quality of life in hypertensive recipients following renal transplantation","volume":"19","author":"Aasebo","year":"2005","journal-title":"Clinical Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/ndt\/16.7.1465","article-title":"Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients","volume":"16","author":"Asberg","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0126|cit126","first-page":"737A","article-title":"Improved long-term graft function and fewer rejection episodes in hypertensive renal transplant patients treated with nifedipine as compared to lisinopril [abstract no: A3731]","volume":"10","author":"Midtvedt","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00007890-200112150-00013","article-title":"Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0128|cit128","first-page":"907A","article-title":"Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial [abstract no: A4744]","volume":"12","author":"Midtvedt","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1034\/j.1399-0012.2001.150611.x","article-title":"Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial","volume":"15","author":"Midtvedt","year":"2001","journal-title":"Clinical Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0130|cit130","first-page":"907A","article-title":"Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a 2 year prospective randomized double-blind single centre study [abstract no: A4743]","volume":"12","author":"Midtvedt","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0131|cit131","first-page":"A308","article-title":"Nifedipine slow release reduces the incidence of acute rejections in hypertensive renal transplant recipients [abstract]","volume":"14","author":"Midtvedt","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007890-200107150-00021","article-title":"Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD003598.pub3-BIB0133|cit133","first-page":"769A","article-title":"Thiazide diuretics for hypertension in kidney transplant recipients using tacrolimus [abstract no: SA-PO629]","volume":"26","author":"Moes","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.ajkd.2016.12.017","article-title":"Chlorthalidone versus amlodipine for hypertension in kidney transplant recipients treated with tacrolimus: a randomized crossover trial","volume":"69","author":"Moes","year":"2017","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0135|cit135","first-page":"1733","article-title":"Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study","volume":"22","author":"Morales","year":"1990","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0136|cit136","first-page":"148","article-title":"Calcium antagonist treatment of recipient attenuates early cyclosporine nephrotoxicity in renal transplantation. A prospective randomized trial [abstract]","volume":"36","author":"Morales","year":"1989","journal-title":"Kidney International"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub3-BIB0137|cit137","first-page":"1537","article-title":"Calcium antagonist treatment of recipients minimizes early cyclosporine nephrotoxicity in renal transplantation: a prospective randomized trial","volume":"21","author":"Morales","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0138|cit138","first-page":"950","article-title":"Long-term protective effect of calcium antagonist (CA) on renal function in hypertensive renal transplant (RT) patients on ciclosporine (CyA) therapy. a five-year prospective randomized study [abstract]","volume":"4","author":"Morales","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/ndt\/8.9.880a","article-title":"Beneficial effects of calcium antagonists on cyclosporin nephrotoxicity after clinical renal transplantation","volume":"8","author":"Morales","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0140|cit140","first-page":"89","article-title":"Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study","volume":"24","author":"Morales","year":"1992","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0141|cit141","first-page":"832","article-title":"Calcium antagonist therapy prevents chronic cyclosporin nephrotoxicity after renal transplantation: A prospective study [abstract]","volume":"6","author":"Morales","year":"1991","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0142|cit142","first-page":"2598","article-title":"Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study","volume":"26","author":"Morales","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ki.1993.61","article-title":"Converting-enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants","volume":"43","author":"Mourad","year":"1993","journal-title":"Kidney International"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0144|cit144","first-page":"369","article-title":"Down regulation of profibrotic gene expression by angiotensin receptor blockers","volume":"12","author":"Nafar","year":"2018","journal-title":"Iranian Journal of Kidney Diseases"},{"issue":"11 Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/01.tp.0000611788.41308.64","article-title":"Angiotensin II receptor blocker inhibitor (ARBs) use after kidney transplantation and safety: a randomized, double blinded placebo-controlled study [abstract no: 232.3]","volume":"103","author":"Shahraki","year":"2019","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1097\/01.tp.0000700776.68216.92","article-title":"Angiotensin II receptor blocker inhibitor use after kidney transplantation and safety: a randomized, double-blinded placebo-controlled study [abstract no: 232.3]","volume":"104","author":"Shahraki","year":"2020","journal-title":"Transplantation"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD003598.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/j.ekir.2019.05.514","article-title":"Angiotensin receptor blockers down regulate profibrotic gene expression [abstract no: SUN-116]","volume":"4","author":"Shahraki","year":"2019","journal-title":"Kidney International Reports"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.transproceed.2009.07.021","article-title":"Effect of angiotensin II type-1 receptor blockers on stable allograft kidneys: prospective randomized study","volume":"41","author":"Nouri-Majalan","year":"2009","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0149|cit149","unstructured":"Nouri-Majalan N Moghaddasi SM Effect of losartan on dynamic tissue perfusing of renal allograft measure by colour Doppler sonography: clinical trial period [abstract no: M-PO-0878] 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil 2007 296"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0150|cit150","first-page":"97","article-title":"Effect of losartan on Doppler sonography indices in kidney transplant patients: a randomized clinical trial","volume":"5","author":"Nouri-Majalan","year":"2009","journal-title":"Vascular Health & Risk Management"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1097\/00007890-199506000-00021","article-title":"Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation","volume":"59","author":"Ok","year":"1995","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0152|cit152","first-page":"1070","article-title":"Comparison of enalapril and theophylline treatment for posttransplant erythrocytosis (PTE) [abstract]","volume":"10","author":"Ok","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0153|cit153","first-page":"vi401","article-title":"Regression of left ventricular hypertrophy by ACE-inhibitors is observed only in cyclosporine and not in tacrolimus - treated renal transplant recipients [abstract no: SaP494]","volume":"22","author":"Paoletti","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/TP.0b013e3182827a43","article-title":"Effects of ACE inhibitors on long-term outcome of renal transplant recipients: a randomized controlled trial","volume":"95","author":"Paoletti","year":"2013","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/j.ajkd.2007.04.013","article-title":"ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial","volume":"50","author":"Paoletti","year":"2007","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00007890-199403270-00021","article-title":"A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome","volume":"57","author":"Patton","year":"1994","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0272-6386(12)81092-4","article-title":"A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients","volume":"21","author":"Pirsch","year":"1993","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0158|cit158","unstructured":"Barenbrock M Breuer J Schroder K Wagner K Neumayer HH Rahn KH A study of the nephroprotective effect of nitrendipine after renal transplantation [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain) 1995 387"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0159|cit159","first-page":"388","article-title":"A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function","volume":"43","author":"Barenbrock","year":"1995","journal-title":"Clinical Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0160|cit160","first-page":"1466","article-title":"Effect of nitrendipine on kidney function after renal transplantation [abstract]","volume":"11","author":"Barenbrock","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9188","key":"10.1002\/14651858.CD003598.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(99)08421-4","article-title":"Effect of nitrendipine on renal function in renal-transplant patients treated with cyclosporin: a randomised trial","volume":"354","author":"Rahn","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/ndt\/12.7.1441","article-title":"Blood pressure independent effects of nitrendipine on cardiac structure in patients after renal transplantation","volume":"12","author":"Rockstroh","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003598.pub3-BIB0163|cit163","first-page":"iv278","article-title":"Enalapril and Losartan affect lipid peroxidation in renal transplant recipients with various renin-angiotensin system polymorphisms [abstract no: SP781]","volume":"21","author":"Aghaeishahsavari","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.transproceed.2007.11.033","article-title":"Effects of losartan and enalapril on high-sensitivity C-reactive protein and total antioxidant in renal transplant recipients with Renin-Angiotensin system polymorphisms","volume":"40","author":"Argani","year":"2008","journal-title":"Transplantation Proceedings"},{"issue":"Abstracts","key":"10.1002\/14651858.CD003598.pub3-BIB0165|cit165","first-page":"820A","article-title":"Prevention of lipid peroxidationand DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms [abstract no: PUB016]","volume":"17","author":"Argani","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10157-007-0001-x","article-title":"Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms","volume":"12","author":"Ghorbanihaghjo","year":"2008","journal-title":"Clinical & Experimental Nephrology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003598.pub3-BIB0167|cit167","first-page":"170","article-title":"Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms [abstract no: P314]","volume":"20","author":"Noroozianavval","year":"2007","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.transproceed.2007.02.016","article-title":"Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril","volume":"39","author":"Noroozianavval","year":"2007","journal-title":"Transplantation Proceedings"},{"issue":"3-4","key":"10.1002\/14651858.CD003598.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.clinbiochem.2006.10.023","article-title":"Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms","volume":"40","author":"Rashtchizadeh","year":"2007","journal-title":"Clinical Biochemistry"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0170|cit170","first-page":"877","article-title":"Does enalapril retard the progression of renal insufficiency in kidney transplant recipients? [abstract]","volume":"3","author":"Riggio","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0171|cit171","first-page":"1921","article-title":"Calcium channel blockade and Cr51-EDTA -clearance in renal transplant patients [abstract no: A3373]","volume":"7","author":"Rump","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00004872-200018080-00017","article-title":"Dihydropyridine calcium antagonists and renal function in hypertensive kidney transplant recipients","volume":"18","author":"Rump","year":"2000","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0173|cit173","unstructured":"Santos AF Keitel E Bittar A Neto JP Alves MD Schaefer PG Long term results of diltiazem use associated to cyclosporin in renal transplantation [abstract no: 3327] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA) 2002"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0174|cit174","first-page":"272","article-title":"The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with cyclosporin [abstract no: 183]","volume":"22","author":"Schmidt","year":"1999","journal-title":"Kidney & Blood Pressure Research"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/ndt\/16.5.1034","article-title":"The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA","volume":"16","author":"Schmidt","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0176|cit176","unstructured":"Schmidt A Gruber U Bohmig G Koller E Mayer G The effect of ace inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with cyclosporin [abstract no: P0565W] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sep 1; Rome, Italy 2000"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0177|cit177","first-page":"746A","article-title":"The effect of ace inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homestasis in hypertensive renal transplant recipients treated with cyclosporin A [abstract no: A3772]","volume":"10","author":"Schmidt","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5-6","key":"10.1002\/14651858.CD003598.pub3-BIB0178|cit178","first-page":"331","article-title":"Study on the evaluation of candesartan cilexetil after renal transplantation (SECRET Study) [abstract no: P04.09]","volume":"27","author":"Philipp","year":"2004","journal-title":"Kidney & Blood Pressure Research"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ndt\/gfp581","article-title":"Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET","volume":"25","author":"Philipp","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.HYP.26.3.436","article-title":"Comparison of perindopril and amlodipine in cyclosporine-treated renal allograft recipients","volume":"26","author":"Sennesael","year":"1995","journal-title":"Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0272-6386(96)90106-7","article-title":"Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients","volume":"27","author":"Sennesael","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"issue":"Suppl 10S","key":"10.1002\/14651858.CD003598.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00007890-201211271-00218","article-title":"Chronic allograft nephropathy - an Indian study [abstract no: 1506]","volume":"94","author":"Sharma","year":"2012","journal-title":"Transplantation"},{"issue":"Suppl 10S","key":"10.1002\/14651858.CD003598.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00007890-201211271-02060","article-title":"Chronic allograft nephropathy-an Indians study [abstract no: 1506]","volume":"94","author":"Sharma","year":"2012","journal-title":"Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000357205","article-title":"Specific management of anemia and hypertension in renal transplant recipients: influence of renin-Angiotensin system blockade","volume":"39","author":"Salzberg","year":"2014","journal-title":"American Journal of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD003598.pub3-BIB0185|cit185","first-page":"231A","article-title":"Interim analysis of the SMAhRT study (Selective Management of Anemia and Hypertension in Renal Transplant Recipients) [abstract no: F-PO601]","volume":"18","author":"Turner","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD003598.pub3-BIB0186|cit186","first-page":"548A","article-title":"Angiotensin receptor blocker's effect on hemoglobin in renal transplant patients - an interim analysis of the specific management of anemia and hypertension in renal transplant recipients trial (SMAhRT) [abstract no: F-PO1007]","volume":"17","author":"Weinstein","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-011-0991-x","article-title":"Combination therapy with diltiazem plus CsA\/MMF\/Pred or CsA\/Aza\/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China","volume":"67","author":"Song","year":"2011","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-011-0991-x","article-title":"Combination therapy with diltiazem plus CsA\/MMF\/Pred or CsA\/Aza\/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China","volume":"67","author":"Song","year":"2011","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF03044784","article-title":"Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients","volume":"92","author":"Sperschneider","year":"1997","journal-title":"Medizinische Klinik"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0190|cit190","first-page":"707A","article-title":"Influence of diltiazem on cyclosporine metabolites in renal graft recipients treated with Sandimmune\u00ae and Neoral\u00ae [abstract no: A3286]","volume":"8","author":"Wagner","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub3-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF03044784","article-title":"Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients","volume":"92","author":"Sperschneider","year":"1997","journal-title":"Medizinische Klinik"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0192|cit192","first-page":"707A","article-title":"Influence of diltiazem on cyclosporine metabolites in renal graft recipients treated with Sandimmune\u00ae and Neoral\u00ae [abstract no: A3286]","volume":"8","author":"Wagner","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0193|cit193","first-page":"486","article-title":"The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity [abstract no: A250]","volume":"16","author":"Mortensen","year":"2016","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"i600","DOI":"10.1093\/ndt\/gfy104.SP748","article-title":"Treatment with spironolactone for 1 year does not improve nitric oxide metabolism in renal transplant patients [abstract no: SP748]","volume":"33","author":"Mortensen","year":"2018","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"F529","DOI":"10.1152\/ajprenal.00025.2019","article-title":"Effect of spironolactone for 1 yr on endothelial function and vascular inflammation biomarkers in renal transplant recipients","volume":"317","author":"Mortensen","year":"2019","journal-title":"American Journal of Physiology - Renal Physiology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12882-018-0885-6","article-title":"The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)","volume":"19","author":"Mortensen","year":"2018","journal-title":"BMC Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"F138","DOI":"10.1152\/ajprenal.00104.2021","article-title":"Mineralocorticoid receptor blockade with spironolactone has no direct effect on plasma IL-17A and injury markers in urine from kidney transplant patients","volume":"322","author":"Thangaraj","year":"2022","journal-title":"American Journal of Physiology - Renal Physiology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0198|cit198","first-page":"382","article-title":"Randomized prospective study of effects of ace inhibitors in renal transplantation: an analysis of safety and efficacy [abstract no: 970]","volume":"2","author":"Kawaguchi","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s101570200041","article-title":"Randomized prospective study of effects of benazepril in renal transplantation: An analysis of safety and efficacy","volume":"6","author":"Takahara","year":"2002","journal-title":"Clinical & Experimental Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/JDI-120017470","article-title":"A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis","volume":"25","author":"Trivedi","year":"2003","journal-title":"Renal Failure"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-6143.2006.01588.x","article-title":"Renal allograft protection with angiotensin II type 1 receptor antagonists","volume":"7","author":"Tylicki","year":"2007","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.tp.0000188137.50178.7d","article-title":"Randomized placebo-controlled study on the effects of losartan and carvedilol on albuminuria in renal transplant recipients","volume":"81","author":"Tylicki","year":"2006","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"221","DOI":"10.18388\/abp.2016_1297","article-title":"Aliskiren reduces albuminuria after kidney transplantation","volume":"64","author":"Tylicki","year":"2017","journal-title":"Acta Biochimica Polonica"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"iii366","DOI":"10.1093\/ndt\/gfv185.55","article-title":"Aliskiren reduces albuminuria after kidney transplantation [abstract no: FP866]","volume":"30","author":"Tylicki","year":"2015","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003598.pub3-BIB0205|cit205","first-page":"268","article-title":"Low-grade albuminuria reduction with angiotensin II type 1 receptor antagonist in renal transplant recipients [abstract no: P-695]","volume":"22","author":"Uchida","year":"2009","journal-title":"Transplant International"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"515","DOI":"10.5301\/JN.2011.6235","article-title":"Low-grade albuminuria reduction with angiotensin II type 1 receptor blocker in renal transplant recipients","volume":"24","author":"Uchida","year":"2011","journal-title":"Journal of Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0207|cit207","first-page":"50","article-title":"Effect of isradipine on cyclosporin A-related hypertension","volume":"3","author":"Van den Dorpel","year":"1994","journal-title":"Blood Pressure"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1111\/j.1432-2277.1994.tb01365.x","article-title":"Prophylactic isradipine treatment after kidney transplantation: a prospective double-blind placebo-controlled randomized trial","volume":"7","author":"Van den Dorpel","year":"1994","journal-title":"Transplantation International"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.HYP.25.1.77","article-title":"Hypertension after renal transplantation. Calcium channel or converting enzyme blockade?","volume":"25","author":"Schaaf","year":"1995","journal-title":"Hypertension"},{"issue":"3 Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0210|cit210","first-page":"615","article-title":"Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients","volume":"20","author":"Vanrenterghem","year":"1988","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0211|cit211","first-page":"122","article-title":"Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study","volume":"70","author":"Riemsdijk","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ndt\/14.2.384","article-title":"Renal effects of amlodipine in normotensive renal transplant recipients","volume":"14","author":"Venkat-Raman","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0213|cit213","unstructured":"Venkat-Raman G Griffin P Moore R Goodship T Effects of amlodipine on renal function and cyclosporine pharmacokinetics in normotensive renal transplant recipients [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain 1995 381"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00007890-199108000-00018","article-title":"Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients","volume":"52","author":"Kunzendorf","year":"1991","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0215|cit215","first-page":"140","article-title":"Prevention of delayed graft function in cadaver kidney transplants by diltiazem: a randomised trial [abstract]","volume":"1","author":"Neumayer","year":"1986","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0216|cit216","first-page":"S87","article-title":"Protective effects of calcium antagonists in human renal transplantation","volume":"36","author":"Neumayer","year":"1992","journal-title":"Kidney International - Supplement"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/08860229209106631","article-title":"Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation","volume":"14","author":"Neumayer","year":"1992","journal-title":"Renal Failure"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0218|cit218","first-page":"465","article-title":"Prevention of delayed graft function in cadaver kidney transplants by diltiazem [abstract]","volume":"31","author":"Neumayer","year":"1987","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1097\/00005344-198710100-00058","article-title":"Prevention of delayed graft function in cadaver kidney transplants by diltiazem: outcome of two prospective, randomized clinical trials","volume":"10 Suppl 10","author":"Neumayer","year":"1987","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0220|cit220","first-page":"141","article-title":"Does the calcium antagonist diltiazem reduce cyclosporin-A nephrotoxicity? [abstract]","volume":"1","author":"Wagner","year":"1986","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000167487","article-title":"Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study","volume":"7","author":"Wagner","year":"1987","journal-title":"American Journal of Nephrology"},{"issue":"36","key":"10.1002\/14651858.CD003598.pub3-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1055\/s-2008-1068635","article-title":"Protective effect of the calcium antagonist diltiazem on acute kidney failure following kidney transplantation. The results of a prospective randomized study","volume":"111","author":"Wagner","year":"1986","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0223|cit223","first-page":"643","article-title":"Clinical evidence for the protective role of the calcium antagonist diltiazem in acute renal failure (ARF) [abstract]","volume":"Supplement","author":"Wagner","year":"1987","journal-title":"Clinical Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0224|cit224","first-page":"171","article-title":"Effect of the calcium antagonist diltiazem on acute kidney failure following kidney transplantation. Results of 2 prospective randomized studies","volume":"82","author":"Wagner","year":"1987","journal-title":"Medizinische Klinik"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub3-BIB0225|cit225","first-page":"1353","article-title":"Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6-month follow-up","volume":"19","author":"Wagner","year":"1987","journal-title":"Transplantation Proceedings"},{"issue":"8468","key":"10.1002\/14651858.CD003598.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0140-6736(85)92646-7","article-title":"Prevention of delayed graft function in cadaver kidney transplants by diltiazem","volume":"2","author":"Wagner","year":"1985","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0227|cit227","first-page":"311","article-title":"Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients","volume":"24","author":"Wahlberg","year":"1992","journal-title":"Transplantation Proceedings"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0228|cit228","first-page":"150","article-title":"Candesartan attenuates angiotensin II and TGF-beta tissue expression in renal biopsies of patients with chronic allograft nephropathy [abstract no: 48]","volume":"2","author":"Wei","year":"2002","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD003598.pub3-BIB0229|cit229","first-page":"338","article-title":"Candesartan reduces expression of angiotensin II and TGF-beta and increases DNA repair enzyme in human chronic allograft nephropathy [abstract no: 725]","volume":"3","author":"Wei","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0230|cit230","first-page":"24A","article-title":"Candesartan reduces DNA damage and increases DNA repair enzyme in renal biopsies of patients with chronic allograft nephropathy [abstract no: SA-FC118]","volume":"13","author":"Wei","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0231|cit231","first-page":"24A","article-title":"Reduced expression of angiotensin II and TGF-beta in renal biopsies of patients with chronic allograft nephropathy by candesartan [abstract no: SA-FC117]","volume":"13","author":"Wei","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0232|cit232","unstructured":"Weir MR Candesartan attenuates angiotensin II and TGF-beta tissue expression in renal biopsies of patients with chronic allograft nephropathy [abstract no: 3447] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (FL) 2002"},{"issue":"Nov","key":"10.1002\/14651858.CD003598.pub3-BIB0233|cit233","first-page":"418A","article-title":"Angiotensin receptor blockade has significant immunomodulatory effects in chronic allograft nephropathy [abstract no: SA-PO553]","volume":"14","author":"Becker","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD003598.pub3-BIB0234|cit234","first-page":"309","article-title":"Chronic type 1 angiotensin II receptor blockade attenuates lymphocyte responsiveness in renal allograft recipients [abstract no: 615]","volume":"3","author":"Becker","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD003598.pub3-BIB0235|cit235","first-page":"355","article-title":"Intragraft oxidative stress and urinary hydrogen peroxide in chronic allograft nephropathy [abstract no: 793]","volume":"3","author":"Djamali","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1523-1755.2005.00318.x","article-title":"ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro","volume":"67","author":"Weidanz","year":"2005","journal-title":"Kidney International"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0237|cit237","first-page":"781","article-title":"Cyclosporin nephrotoxicity is not ameliorated by nifedipine [abstract]","volume":"7","author":"Wilkie","year":"1992","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD003598.pub3-BIB0238|cit238","first-page":"612","article-title":"Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients","volume":"25","author":"Wilkie","year":"1993","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0239|cit239","unstructured":"Wilkie ME Beer JC Evans C Lord RH Raftery MJ Marsh FP A prospective randomized double-blind placebo-controlled trial of oral nifedipine on early renal allograft function [abstract] 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel 1993 156"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0240|cit240","first-page":"1053","article-title":"Prospective trial of oral nifedipine on early renal allograft function [abstract]","volume":"8","author":"Wilkie","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/ndt\/9.7.800","article-title":"A double-blind, randomized, placebo-controlled study of nifedipine on early renal allograft function","volume":"9","author":"Wilkie","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00007890-200108150-00035","article-title":"Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study","volume":"72","author":"Yildiz","year":"2001","journal-title":"Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0243|cit243","first-page":"A302","article-title":"The effect of enalapril and losartan in posttransplant erythrocytosis [abstract]","volume":"14","author":"Yildiz","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0244|cit244","first-page":"806","article-title":"Treatment of chronic allograft nephropathy with combination of enalapril and bailing capsule","volume":"28","author":"Zhang","year":"2008","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi [Chinese Journal of Integrated Traditional & Western Medicine]"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1016\/j.transproceed.2009.06.225","article-title":"Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study","volume":"41","author":"Zhu","year":"2009","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0246|cit246","unstructured":"Alexander JW Metze TJ Goodman HR Greenberg NA First MR McIntosh MJ Transplant success and immunomodulating diets [abstract] XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami, FL 2002"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD003598.pub3-BIB0247|cit247","first-page":"562","article-title":"Transplant success and immunomodulating diets [abstract]","volume":"3","author":"Alexander","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.TP.0000148802.04879.27","article-title":"The influence of immunomodulatory diets on transplant success and complications","volume":"79","author":"Alexander","year":"2005","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0249|cit249","unstructured":"Alexander JW Ofstedal T Stanley L Erickson A Greenberg N First MR L-arginine and canola oil improve outcome after renal transplantation [abstract] XVIII International Congress of the Transplantation Society; 2000 Aug 27-Sept 1; Rome, Italy 2000"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0250|cit250","first-page":"745","article-title":"Calcium blocker before cyclosporin A in kidney recipients [abstract]","volume":"5","author":"Bourbigot","year":"1990","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2125.1996.34412.x","article-title":"Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients","volume":"41","author":"Bleck","year":"1996","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0252|cit252","first-page":"2159","article-title":"Are cytochrome P450 3A enzymes in the small intestine responsible for different cyclosporine metabolite patterns in stable male and female renal allograft recipients after co-administration of diltiazem?","volume":"28","author":"Christians","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0253|cit253","first-page":"2174","article-title":"Verapamil improves Sandimmune immunosuppression, reducing acute rejection episodes","volume":"28","author":"Citterio","year":"1996","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0254|cit254","first-page":"855","article-title":"DA1 receptor agonist lowers renal vascular resistance in kidney transplant patients on cyclosporine [abstract]","volume":"3","author":"Curtis","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1681\/ASN.V391570","article-title":"Captopril-induced fall in glomerular filtration rate in cyclosporine-treated hypertensive patients","volume":"3","author":"Curtis","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0256|cit256","first-page":"575","article-title":"Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil","volume":"48","author":"Dawidson","year":"1989","journal-title":"Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1016\/S0041-1345(99)00736-8","article-title":"The effects of diltiazem and dopamine on early graft function in renal transplant recipients","volume":"31","author":"Donmez","year":"1999","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0258|cit258","first-page":"289","article-title":"Verapamil prevents post-transplant oliguric renal failure","volume":"24","author":"Duggan","year":"1985","journal-title":"Clinical Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0259|cit259","first-page":"595","article-title":"EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial","volume":"19","author":"Girerd","year":"2018","journal-title":"Trials [Electronic Resource]"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0260|cit260","first-page":"1683","article-title":"ESCORT Trial - Effects of strict control of blood pressure in pediatric renal transplant recipients - 1 year results from a randomized controlled trial [abstract no: O75]","volume":"29","author":"Seeman","year":"2014","journal-title":"Pediatric Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub3-BIB0261|cit261","first-page":"1727","article-title":"ESCORT trial-Effects of strict control of blood pressure in pediatric renal transplant recipients-Final results from a randomized controlled trial [abstract no: FP-S05-2]","volume":"31","author":"Seeman","year":"2016","journal-title":"Pediatric Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0262|cit262","first-page":"1531","article-title":"ESCORT trial-effects of strict control of blood pressure in pediatric renal transplant recipients-baseline characteristics of patients from a randomized controlled trial [abstract no: P-SAT456]","volume":"28","author":"Seeman","year":"2013","journal-title":"Pediatric Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0263|cit263","first-page":"1562","article-title":"ESCORT trial-effects of strict control of blood pressure in pediatric renal transplant recipients-2 year results from a randomized controlled trial [abstract no: O-54]","volume":"30","author":"Seeman","year":"2015","journal-title":"Pediatric Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0264|cit264","first-page":"63","article-title":"ESCORT trial-effects of strict control of blood pressure in pediatric renal transplant recipients-final results from a randomized controlled trial [abstract no: P.214]","volume":"21","author":"Seeman","year":"2017","journal-title":"Pediatric Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"e13329","DOI":"10.1111\/petr.13329","article-title":"Effects of the strict control of blood pressure in pediatric renal transplant recipients-ESCORT trial","volume":"23","author":"Seeman","year":"2019","journal-title":"Pediatric Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0266|cit266","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00007890-201407151-02883","article-title":"A pilot study to evaluate the impact of nebivolol versus metoprolol on quality of life measures in stable renal transplant recipients [abstract no: D2732]","volume":"98","author":"Gabardi","year":"2014","journal-title":"Transplantation"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD003598.pub3-BIB0267|cit267","first-page":"1066A","article-title":"Evaluation of irbesartan and losartan on renal protection in renal transplant recipients (I-LORD study) [abstract no: PUB779]","volume":"23","author":"Yokoyama","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0268|cit268","first-page":"311","article-title":"Platelet inhibitors in human renal homotransplantation: randomized comparison of aspirin versus dipyridamole","volume":"12","author":"Kauffman","year":"1980","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0148607101025004194","article-title":"Oral arginine improves blood pressure in renal transplant and hemodialysis patients","volume":"25","author":"Kelly","year":"2001","journal-title":"Jpen - Journal of Parenteral & Enteral Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0270|cit270","first-page":"905","article-title":"Does systemic pretreatment with verapamil prevent acute tubular necrosis after renal transplantation?","volume":"20","author":"Koller","year":"1988","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0271|cit271","first-page":"A227","article-title":"Long term effects of two ace inhibitors on erythropoiesis in renal transplantation [abstract]","volume":"12","author":"Konstadinidou","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0272|cit272","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0019-5049.199853","article-title":"Effect of discontinuing morning dose of antihypertensive for renal transplant surgery on haemodynamic and early graft functioning: A prospective, double-blind, randomised study","volume":"61","author":"Kumar","year":"2017","journal-title":"Indian Journal of Anaesthesia"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0273|cit273","first-page":"113","article-title":"The effect of a single oral dose of a calcium-channel blocker on renal function in kidney transplant recipients","volume":"16","author":"Lal","year":"1999","journal-title":"Advances in Therapy"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/00005344-199311000-00006","article-title":"Systemic and renal hemodynamic responses to carvedilol and metoprolol in hypertensive renal transplant patients","volume":"22","author":"Leeman","year":"1993","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0275|cit275","first-page":"56A","article-title":"Add-on pentoxifylline attenuated residual proteinuria in patients of moderate to advanced chronic kidney disease receiving maximized losartan treatment [abstract no: F-FC090]","volume":"17","author":"Lin","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ajkd.2008.05.012","article-title":"Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial","volume":"52","author":"Lin","year":"2008","journal-title":"American Journal of Kidney Diseases"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0277|cit277","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/00365519509110262","article-title":"Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone","volume":"55","author":"Madsen","year":"1995","journal-title":"Scandinavian Journal of Clinical & Laboratory Investigation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0278|cit278","unstructured":"Madsen JK Zachariae H Pedersen EB Beneficial effects of felodipine on renal hemodynamics, tubular sodium handling, and blood pressure in cyclosporine-treated dermatological patients [abstract] ISN XIII International Congress of Nephrology; 1995 Jul 2-6; Madrid, Spain 1995 36"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0279|cit279","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.intimp.2004.09.025","article-title":"Vasodilatation vs. immunotherapy to prevent delayed graft function: delayed graft function as an indication of immune activation","volume":"5","author":"McCune","year":"2005","journal-title":"International Immunopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0280|cit280","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1097\/TXD.0000000000000861","article-title":"Effects of telmisartan and candesartan on the metabolism of lipids and glucose in kidney transplant patients: a prospective, randomized crossover study","volume":"5","author":"Miura","year":"2019","journal-title":"Transplantation Direct"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0281|cit281","first-page":"623","article-title":"Randomized controlled trial of spironolactone effect in kidney transplant recipients of living donors [abstract no: A91]","volume":"19","author":"Bobadilla","year":"2019","journal-title":"American Journal of Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0282|cit282","doi-asserted-by":"crossref","first-page":"F519","DOI":"10.1152\/ajprenal.00606.2018","article-title":"Spironolactone reduces oxidative stress in living donor kidney transplantation: a randomized controlled trial","volume":"317","author":"Morales-Buenrostro","year":"2019","journal-title":"American Journal of Physiology - Renal Physiology"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0041-1345(00)00886-1","article-title":"Increased incidence of infection in verapamil-treated kidney transplant recipients","volume":"32","author":"Nanni","year":"2000","journal-title":"Transplantation Proceedings"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0284|cit284","unstructured":"Safety and efficacy of enteric-coated mycophenolate sodium (EC-MPS) plus valsartan in patients with kidney transplants (MYTHOS) www.clinicaltrials.gov\/ct2\/show\/record\/NCT00308425"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0285|cit285","unstructured":"Reduction of nocturnal hypertension in pediatric renal transplant recipients www.clinicaltrials.gov\/ct2\/show\/NCT01007994"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0286|cit286","unstructured":"Telmisartan versus losartan in kidney transplantation (COSTANT) www.clinicaltrials.gov\/ct2\/show\/NCT01224860"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0287|cit287","unstructured":"The management of resistant hypertension in kidney transplant patients using chlorthalidone www.clinicaltrials.gov\/ct2\/show\/NCT02030314"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub3-BIB0288|cit288","first-page":"1221","article-title":"Prevention of delayed graft function by diltiazem and iloprost","volume":"21","author":"Neumayer","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0289|cit289","first-page":"572","article-title":"Prevention of delayed graft function in cadaver kidney transplants by the calcium antagonist diltiazem and the prostacyclin analogue Iloprost: outcome of a prospective randomised clinical trial [abstract]","volume":"3","author":"Neumayer","year":"1988","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0290|cit290","first-page":"289","article-title":"Prevention of delayed graft function in cadaveric kidney transplants by the calcium antagonist diltiazem and the prostacyclin-analogue iloprost--outcome of a prospective randomized clinical trial","volume":"301","author":"Neumayer","year":"1989","journal-title":"Progress in Clinical & Biological Research"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/00007890-198906000-00032","article-title":"A controlled trial of dipyridamole as an immunomodulator in renal allograft recipients","volume":"47","author":"Niyamathullah","year":"1989","journal-title":"Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/00007890-200003270-00014","article-title":"Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules","volume":"69","author":"Noel","year":"2000","journal-title":"Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0293|cit293","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1399-0012.1997.tb00800.x","article-title":"A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft","volume":"11","author":"Noel","year":"1997","journal-title":"Clinical Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0294|cit294","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00007890-199802150-00015","article-title":"Improvement in the outcome of rejection with pentoxifylline in renal transplantation: a randomized controlled trial","volume":"65","author":"Noel","year":"1998","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1055\/s-0037-1614112","article-title":"Pentoxifylline prevents upregulation of monocyte tissue factor in renal transplant recipients undergoing post-graft complications","volume":"84","author":"Susen","year":"2000","journal-title":"Thrombosis & Haemostasis"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000350539","article-title":"Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: A double-blind, randomized pilot study","volume":"37","author":"Ojeda-Cervantes","year":"2013","journal-title":"American Journal of Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003598.pub3-BIB0297|cit297","first-page":"369","article-title":"Effect of mineralocorticoid receptor blockade on the phenomenon of ischemia reperfusion in renal transplantation: a pilot study [abstract no: 1157]","volume":"12","author":"Ojeda-Cerventes","year":"2012","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0298|cit298","first-page":"87","article-title":"Hemodynamic effects of amrinone combined with dopamine in patients undergoing living renal transplantation","volume":"46","author":"Okuno","year":"1997","journal-title":"Masui - Japanese Journal of Anesthesiology"},{"issue":"8812","key":"10.1002\/14651858.CD003598.pub3-BIB0299|cit299","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0140-6736(92)93212-6","article-title":"Effect of preservation solution on results of cadaveric kidney transplantation. The European Multicentre Study Group","volume":"340","author":"Ploeg","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0300|cit300","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00007890-199002000-00011","article-title":"Kidney preservation with the UW and Euro-Collins solutions. A preliminary report of a clinical comparison","volume":"49","author":"Ploeg","year":"1990","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0301|cit301","first-page":"2213","article-title":"Preliminary results of the European Multicenter Trial of UW and Euro-Collins solutions in kidney transplantation. The Study Group","volume":"22","author":"Ploeg","year":"1990","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0302|cit302","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00007890-199310000-00015","article-title":"The cost-effectiveness of preservation with UW and EC solution for use in cadaveric kidney transplantation in the case of single kidney donors","volume":"56","author":"Rutten","year":"1993","journal-title":"Transplantation"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub3-BIB0303|cit303","first-page":"1586","article-title":"Kidney preservation with University of Wisconsin or Euro-Collins solution? An economic analysis","volume":"25","author":"Rutten","year":"1993","journal-title":"Transplantation Proceedings"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0304|cit304","first-page":"956","article-title":"Effect of varying doses of enalapril on post-transplant erythocytosis [abstract]","volume":"4","author":"Po","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0305|cit305","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/jsre.1999.5652","article-title":"Prostaglandin E1 influences pulsatile preservation characteristics and early graft function in expanded criteria donor kidneys","volume":"85","author":"Polyak","year":"1999","journal-title":"Journal of Surgical Research"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"M610","DOI":"10.1097\/00002480-199809000-00062","article-title":"Prostaglandin E1 improves pulsatile preservation characteristics and early graft function in expanded criteria donor kidneys","volume":"44","author":"Polyak","year":"1998","journal-title":"ASAIO Journal"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0307|cit307","first-page":"52","article-title":"A multivariate analysis of the risk factors for posttransplant renal failure: beneficial effect of a flush solution with mannitol","volume":"24","author":"Porras","year":"1992","journal-title":"Transplantation Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0308|cit308","first-page":"2368","article-title":"Usefulness of diltiazem in reducing the incidence of acute tubular necrosis in Euro-Collins-preserved cadaveric renal grafts","volume":"23","author":"Puig","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub3-BIB0309|cit309","first-page":"1228","article-title":"Mannitol reduces ATN in cadaveric allografts","volume":"21","author":"Richards","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"12","key":"10.1002\/14651858.CD003598.pub3-BIB0310|cit310","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s004670000400","article-title":"A randomized prospective crossover trial of amlodipine in pediatric hypertension","volume":"14","author":"Rogan","year":"2000","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ki.1993.227","article-title":"Role of the renin-angiotensin system on the renal functional reserve in renal transplant recipients","volume":"44","author":"Rondeau","year":"1993","journal-title":"Kidney International"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0312|cit312","first-page":"779","article-title":"Renal functional reserve in renal transplant recipients [abstract]","volume":"7","author":"Rondeau","year":"1992","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0313|cit313","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/clpt.1989.202","article-title":"Short-term effects of calcium antagonists on hemodynamics and cyclosporine pharmacokinetics in heart-transplant and kidney-transplant patients","volume":"46","author":"Roy","year":"1989","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0314|cit314","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/jch.12745","article-title":"Nebivolol effects on nitric oxide levels, blood pressure, and renal function in kidney transplant patients","volume":"18","author":"Casey","year":"2016","journal-title":"Journal of Clinical Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0315|cit315","first-page":"415","article-title":"Intraoperative cortical PO2 measurement in kidney transplantation. The effect of the calcium antagonist diltiazem","volume":"33","author":"Schott","year":"1994","journal-title":"Urologe (Ausgabe A)"},{"issue":"Abstract Suppl","key":"10.1002\/14651858.CD003598.pub3-BIB0316|cit316","first-page":"543","article-title":"Reduction of nocturnal hypertension in pediatric renal transplant recipients [abstract no: FR-PO544]","volume":"28","author":"Sethna","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0317|cit317","doi-asserted-by":"crossref","first-page":"e13854","DOI":"10.1111\/petr.13854","article-title":"Restoration of nocturnal blood pressure dip and reduction of nocturnal blood pressure with evening anti-hypertensive medication administration in pediatric kidney transplant recipients: a pilot randomized clinical trial","volume":"24","author":"Sethna","year":"2020","journal-title":"Pediatric Transplantation"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub3-BIB0318|cit318","first-page":"1230","article-title":"A prospective randomized study of the protective effect of verapamil on ischemic renal injury in renal allotransplants","volume":"21","author":"Sobh","year":"1989","journal-title":"Transplantation Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0319|cit319","first-page":"1116","article-title":"Effect of calcium-channel blockade on renal hemodynamics and cyclosporine (CSA) pharmacokinetcis in randomized double-blind dose-response study in stable renal allograft recipients [abstract no: 1120]","volume":"6","author":"Sonzogni","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub3-BIB0320|cit320","first-page":"833","article-title":"Renal haemodynamic and tubular effects of felodipine in cyclosporin-treated renal transplant recipients [abstract]","volume":"6","author":"Sorensen","year":"1991","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0321|cit321","first-page":"S94","article-title":"Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies","volume":"55","author":"Pedersen","year":"1996","journal-title":"Kidney International - Supplement"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0322|cit322","first-page":"S82","article-title":"Interaction between cyclosporine and felodipine in renal transplant recipients","volume":"36","author":"Pedersen","year":"1992","journal-title":"Kidney International - Supplement"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0323|cit323","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.ndt.a091993","article-title":"Effect of felodipine on renal haemodynamics and tubular sodium handling in cyclosporin-treated renal transplant recipients","volume":"7","author":"Sorensen","year":"1992","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/00005344-199106181-00019","article-title":"Cardiovascular side effects after renal allograft rejection therapy with Orthoclone: prevention with nitrendipine","volume":"18 Suppl 1","author":"Spieker","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD003598.pub3-BIB0325|cit325","first-page":"540","article-title":"Effects of ace inhibitors and beta-blockers on arterial compliance [abstract]","volume":"4","author":"Spieker","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0326|cit326","doi-asserted-by":"crossref","first-page":"14247","DOI":"10.1038\/s41598-022-18552-7","article-title":"The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial","volume":"12","author":"Susomboon","year":"2022","journal-title":"Scientific Reports"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD003598.pub3-BIB0327|cit327","first-page":"1334","article-title":"Kidney protective effect of diltiazem after renal transplantation with long cold ischemia time and triple-drug immunosuppression","volume":"23","author":"Tenschert","year":"1991","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub3-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/ndt\/13.10.2612","article-title":"Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients","volume":"13","author":"Venkat-Raman","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0329|cit329","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.jash.2014.03.230","article-title":"Effect of bedtime BP medication use on day-night BP change, GFR and echocardiographic findings in kidney transplant recipients [abstract]","volume":"8","author":"Wadei","year":"2014","journal-title":"Journal of the American Society of Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.transproceed.2013.11.121","article-title":"Effects of atorvastatin on the pharmacokinetics of everolimus among kidney transplant recipients","volume":"46","author":"Wanitchanont","year":"2014","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0041-1345(00)01266-5","article-title":"Effects of pentoxifylline treatment on delayed graft function in cadaveric kidney recipients","volume":"32","author":"Wlodarczyk","year":"2000","journal-title":"Transplantation Proceedings"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0332|cit332","first-page":"A265","article-title":"The interaction between cyclosporine A and verapamil, felodipine and isradipine [abstract]","volume":"12","author":"Yildiz","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0333|cit333","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000045262","article-title":"Interaction between cyclosporine A and verapamil, felodipine, and isradipine","volume":"91","author":"Yildiz","year":"1999","journal-title":"Nephron"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0334|cit334","first-page":"A217","article-title":"The interaction between cyclosporine A and verapamil, felodipine and isradipine [abstract]","volume":"12","author":"Yildiz","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD003598.pub3-BIB0335|cit335","first-page":"163","article-title":"Clinical study on Lipo PGE, inhibiting platelets activation in acute rejection after kidney transplantation [abstract]","volume":"4","author":"Zhang","year":"2004","journal-title":"American Journal of Transplantation"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub3-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1016\/j.transproceed.2005.10.122","article-title":"Clinical study of Lipo PGE1-inhibiting platelet activation in acute rejection after kidney transplantation","volume":"37","author":"Zhang","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0337|cit337","first-page":"3013","article-title":"Bolus injection versus infusion of furosemide in kidney transplantation: a randomized clinical trial","volume":"14","author":"Zomorrodi","year":"2017","journal-title":"Urology Journal"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0338|cit338","doi-asserted-by":"publisher","first-page":"755-66","DOI":"10.2215\/CJN.0000000000000439","article-title":"Effect of spironolactone on kidney function in kidney transplant recipients (the SPIREN trial): a randomized placebo-controlled clinical trial","volume":"19","author":"Mortensen","year":"2024","journal-title":"Clinical Journal of the American Society of Nephrology: CJASN"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0339|cit339","unstructured":"ALLOGRAFT, a study to evaluate the renal protective effects of losartan www.clinicaltrials.gov\/ct2\/show\/NCT00140907"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0340|cit340","unstructured":"The effect of eplerenone on the evolution of vasculopathy in renal transplant patients (EVATRAN) www.clinicaltrials.gov\/ct2\/show\/NCT04450953"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"e000091","DOI":"10.1161\/JAHA.112.000091","article-title":"Beta and angiotensin blockades are associated with improved 10-year survival in renal transplant recipients","volume":"2","author":"Aftab","year":"2013","journal-title":"Journal of the American Heart Association"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0342|cit342","doi-asserted-by":"crossref","first-page":"1074\u201381","DOI":"10.1097\/HJH.0000000000000510","article-title":"Prevalence and clinical characteristics of renal transplant patients with true resistant hypertension","volume":"33","author":"Arias-Rodr\u0131guez","year":"2015","journal-title":"Journal of Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0343|cit343","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/ajt.14702","article-title":"An economic assessment of contemporary kidney transplant practice","volume":"18","author":"Axelrod","year":"2018","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00003495-200868001-00005","article-title":"Mechanisms and management of proteinuria in kidney transplant patients","volume":"68 Suppl 1","author":"Barama","year":"2008","journal-title":"Drugs"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0345|cit345","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1592\/phco.23.6.788.32180","article-title":"Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: fact or fiction","volume":"23","author":"Baroletti","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0346|cit346","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1681\/ASN.2013040435","article-title":"BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"25","author":"Carpenter","year":"2014","journal-title":"Journal of American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0347|cit347","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/dme.14107","article-title":"Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria","volume":"37","author":"Coleman","year":"2020","journal-title":"Diabetic Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1681\/ASN.V1061253","article-title":"Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis","volume":"10","author":"Cordonnier","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7650","key":"10.1002\/14651858.CD003598.pub3-BIB0349|cit349","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0350|cit350","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD003598.pub3-BIB0351|cit351","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1097\/HJH.0000000000001586","article-title":"Optimizing hypertension management in renal transplantation: a call to action [Erratum in: J Hypertens. 2019 Aug;37(8):1734]","volume":"35","author":"Halimi","year":"2017","journal-title":"Journal of Hypertension"},{"issue":"7414","key":"10.1002\/14651858.CD003598.pub3-BIB0352|cit352","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0353|cit353","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub3-BIB0354|cit354","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1432-2277.2009.00922.x","article-title":"Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients","volume":"22","author":"Hillebrand","year":"2009","journal-title":"Transplant International"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0355|cit355","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","article-title":"Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: a meta-analysis of randomized controlled trials","volume":"69","author":"Hiremath","year":"2017","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0356|cit356","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/fca.14.51","article-title":"Vasodilator beta-blockers: a different class of antihypertensive agents?","volume":"10","author":"Kallistratos","year":"2014","journal-title":"Future Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0357|cit357","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"American Journal of Transplantation"},{"issue":"2 Suppl 2","key":"10.1002\/14651858.CD003598.pub3-BIB0358|cit358","first-page":"S12","article-title":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease","volume":"49","author":"Kidney Disease Outcomes Quality Initiative (K\/DOQI)","year":"2007","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0359|cit359","doi-asserted-by":"crossref","first-page":"116\u201325","DOI":"10.1016\/j.phrs.2017.07.026","article-title":"Antihypertensive drugs","volume":"124","author":"Laurent","year":"2017","journal-title":"Pharmacological Research"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub3-BIB0360|cit360","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1097\/HJH.0000000000003246","article-title":"Impact of donor hypertension on graft survival and function in living and deceased donor kidney transplantation: a nationwide prospective cohort study","volume":"40","author":"Lee","year":"2022","journal-title":"Journal of Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0361|cit361","doi-asserted-by":"publisher","first-page":"49\u201361","DOI":"10.1038\/ki.2013.444","article-title":"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward","volume":"85","author":"Levin","year":"2013","journal-title":"Kidney International"},{"issue":"9","key":"10.1002\/14651858.CD003598.pub3-BIB0362|cit362","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/ndt\/gfq792","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials","volume":"26","author":"Maione","year":"2011","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0363|cit363","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1681\/ASN.2018050531","article-title":"Projecting ESRD Incidence and Prevalence in the United States through 2030","volume":"30","author":"McCullough","year":"2019","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub3-BIB0364|cit364","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0365|cit365","unstructured":"Nachawati D Patel JB Alpha-Blockers. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan- www.ncbi.nlm.nih.gov\/books\/NBK556066\/"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0366|cit366","first-page":"S79","article-title":"The CARI guidelines. Prevention of progression of kidney disease. ACE inhibitor treatment in diabetic nephropathy","volume":"11","author":"Nicholls","year":"2006","journal-title":"Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub3-BIB0367|cit367","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/j.1600-6143.2005.01093.x","article-title":"Improved long-term outcomes after renal transplantation associated with blood pressure control","volume":"5","author":"Opelz","year":"2005","journal-title":"American Journal of Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0368|cit368","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/01.TP.0000437672.78716.28","article-title":"Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers","volume":"97","author":"Opelz","year":"2014","journal-title":"Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0369|cit369","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006743.pub2","article-title":"Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event","author":"Perez","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003598.pub3-BIB0370|cit370","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/TP.0b013e3181caeead","article-title":"Reduction in cardiovascular death after kidney transplantation","volume":"89","author":"Pilmore","year":"2010","journal-title":"Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD003598.pub3-BIB0371|cit371","doi-asserted-by":"crossref","first-page":"878\u201387","DOI":"10.1093\/ndt\/gfz092","article-title":"Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis","volume":"35","author":"Pisano","year":"2020","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0372|cit372","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1432-2277.2011.01242.x","article-title":"Hypertension in kidney transplant recipients","volume":"24","author":"Ponticelli","year":"2011","journal-title":"Transplant International"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0373|cit373","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1524-6175.2007.07125.x","article-title":"Direct renin inhibitors: a new approach to antihypertensive drug treatment","volume":"9","author":"Ram","year":"2007","journal-title":"Journal of Clinical Hypertension"},{"issue":"13","key":"10.1002\/14651858.CD003598.pub3-BIB0374|cit374","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.2174\/1381612820666141112160013","article-title":"Chemistry and pharmacology of angiotensin-converting enzyme inhibitors","volume":"21","author":"Regulski","year":"2015","journal-title":"Current Pharmaceutical Design"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0375|cit375","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0376|cit376","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0377|cit377","volume-title":"Hypertension: A companion to Braunwald\u2019s Heart Disease","author":"Sica","year":"2007"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0378|cit378","doi-asserted-by":"crossref","first-page":"235","DOI":"10.14797\/mdcj-11-4-235","article-title":"Mineralocorticoid receptor antagonists for treatment of hypertension and heart failure","volume":"11","author":"Sica","year":"2015","journal-title":"Methodist DeBakey Cardiovascular Journal"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0379|cit379","unstructured":"The SONG Handbook Version1.0 www.songinitiative.org\/reports-and-publications (accessed 20 November 2020) 2020"},{"issue":"10","key":"10.1002\/14651858.CD003598.pub3-BIB0380|cit380","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1097\/TP.0000000000001002","article-title":"Survival benefit in renal transplantation despite high comorbidity","volume":"100","author":"Sorensen","year":"2016","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0381|cit381","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/genes11020211","article-title":"Inhibition of angiotensin-converting enzyme ameliorates renal fibrosis by mitigating DPP-4 level and restoring antifibrotic MicroRNAs","volume":"11","author":"Srivastava","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0382|cit382","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fmed.2020.00229","article-title":"Approach and management of hypertension after kidney transplantation","volume":"7","author":"Tantisattamo","year":"2020","journal-title":"Frontiers in Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003598.pub3-BIB0383|cit383","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00007890-201407151-02178","article-title":"Incidence and prevalence of renal transplantation throughout the world: an analysis of the change in renal transplantation rates between years 1990 and 2010 [abstract no: D2526]","volume":"98","author":"Thomas","year":"2014","journal-title":"Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD003598.pub3-BIB0384|cit384","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0385|cit385","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/TP.0000000000001774","article-title":"Toward establishing core outcome domains for trials in kidney transplantation: report of the standardized outcomes in nephrology- Kidney transplantation consensus workshops","volume":"101","author":"Tong","year":"2017","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD003598.pub3-BIB0386|cit386","unstructured":"United States Renal Data System: NIDDK 2020 USRDS Annual Data Report: End Stage Renal Disease https:\/\/usrds-adr.niddk.nih.gov\/2020\/end-stage-renal-disease"},{"issue":"6","key":"10.1002\/14651858.CD003598.pub3-BIB0387|cit387","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2014080834","article-title":"Assessment and management of hypertension in transplant patients","volume":"26","author":"Weir","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD003598.pub3-BIB0388|cit388","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0389|cit389","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003598.pub3-BIB0390|cit390","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40265-020-01290-3","article-title":"ACE inhibitor benefit to kidney and cardiovascular outcomes for patients with non-dialysis chronic kidney disease stages 3-5: a network meta\u2011analysis of randomised clinical trials","volume":"80","author":"Zhang","year":"2020","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD003598.pub3-BIB0391|cit391","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003598.pub2","article-title":"Antihypertensive treatment for kidney transplant recipients","author":"Cross","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003598.pub3-BIB0392|cit392","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/TP.0b013e3181a9e960","article-title":"Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials","volume":"88","author":"Cross","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD003598.pub3-BIB0393|cit393","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003598","article-title":"Antihypertensive treatment for kidney transplant recipients","author":"Risler","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:13:23Z","timestamp":1765757603000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003598.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":393,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003598.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}